Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cardiovascular Research

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0008-6363(00)00013-4PMID 10727660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective stimulation of the parasympathetic preganglionic nerve fibres in the excised and blood-perfused SA node preparation of the dog

  2004cited by this paper
• Preoperative assessment of adenylylcyclase activity as a functional marker of islet cell quality after transplantation in rats.

  1999cited by this paper
• Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells

  1999cited by this paper
• Measurement of the

  1998cited by this paper
• Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate

  1998cited by this paper
• Molecular diversity of sphingolipid signalling

  1997cited by this paper
• Measurement of adenylylcyclase activity in the AV nodal region of the canine heart: evidence for inhibition by adenosine and acetylcholine.

  1997cited by this paper
• Sphingosine 1-Phosphate Induces Platelet Activation through an Extracellular Action and Shares a Platelet Surface Receptor with Lysophosphatidic Acid*

  1997cited by this paper
• Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

  1997cited by this paper
• A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1‐phosphate in atrial myocytes.

  1996cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

  1996cited by this paper
• Characterization of Magnesium Sulfate as an Antiarrhythmic Agent.

  1996cited by this paper
• Activation of a High Affinity G Protein-coupled Plasma Membrane Receptor by Sphingosine-1-phosphate (*)

  1996cited by this paper
• Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.

  1995cited by this paper
• Activation of muscarinic K+ current in guinea‐pig atrial myocytes by sphingosine‐1‐phosphate.

  1995cited by this paper
• Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction

  1995cited by this paper
• Measurement of adenylylcyclase activity with an enzymatic fluorometric assay.

  1995cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Insights into the pathogenesis of acute ischemic syndromes.

  1988cited by this paper
• Pharmacological evidence of autonomic nerve activities in canine papillary muscle.

  1970cited by this paper

• 20(S)-Ginsenoside Rg2 amino acid derivatives for anti hemorrhagic shock: Synthesis, characterization and evaluation.

  2023cites this paper
• Circular Network of Coregulated Sphingolipids Dictates Chronic Hypoxia Damage in Patients With Tetralogy of Fallot

  2022cites this paper
• Opposing Roles of S1P3 Receptors in Myocardial Function

  2020cites this paper
• Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.

  2019cites this paper
• Sphingosine-1-phosphate signaling in blood pressure regulation.

  2019cites this paper
• Sphingosine-1-Phosphate Enhances α1-Adrenergic Vasoconstriction via S1P2–G12/13–ROCK Mediated Signaling

  2019cites this paper
• Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases

  2019cites this paper
• Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study

  2017cites this paper
• Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications

  2016cites this paper
• Implication of sphingosin-1-phosphate in cardiovascular regulation.

  2016cites this paper
• Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.

  2014cites this paper
• Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment

  2014cites this paper
• Testing metabolic and pharmacological agents for recovery following de novo acute heart failure in an isolated rat heart model

  2014cites this paper
• Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction.

  2014cites this paper
• CHAPTER 15 Sphingosine 1-Phosphate ( S 1 P ) Signaling and the Vasculature

  2013cites this paper
• Identification of a pepducin acting as S1P3 receptor antagonist

  2013cites this paper
• Sphingosine-1-Phosphate and Fingolimod (FTY720) Regulate ICl,swell In HL-1 Cardiac Myocytes via Intracellular Binding And Mitochondrial ROS Production

  2013cites this paper
• Sphingosine 1‐Phosphate (S1P) Signaling and the Vasculature

  2013cites this paper
• Mechanisms and Models for Elucidating the Cardiac Effects of Sphingosine 1‐Phosphate (S1P)

  2013cites this paper
• The Role of Sphingosine-1-Phosphate in Breast Cancer Tumor-Induced Lymphangiogenesis

  2012cites this paper
• The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat

  2012cites this paper
• Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases

  2011cites this paper
• Role of the SAFE pathway and the mitochondria in HDL cholesterol (and its constituent sphingosine-1-phosphate) induced cardioprotection

  2011cites this paper
• Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists.

  2010cites this paper
• Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P3 Receptor: Investigation Based on a New S1P3 Receptor Antagonist

  2010cites this paper
• Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries.

  2010cites this paper
• Sphingosine 1-Phosphate ( S 1 P ) Regulates Vascular Contraction via S 1 P 3 Receptor : Investigation Based on a New S 1 P 3 Receptor Antagonist

  2010cites this paper
• Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.

  2009cites this paper
• Lyase to live by: Sphingosine phosphate lyase as a therapeutic target

  2009cites this paper
• Sphingosine 1-Phosphate as a Platelet-Derived Bioactive Lipid

  2008cites this paper
• Sphingosine-1-phosphate receptor signalling in the heart.

  2008cites this paper
• Stratification of Sphingosine Kinase-1 Expression and Activity in Rat Kidney

  2008cites this paper
• “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets

  2008cites this paper
• Multifaceted roles of sphingosine‐1‐phosphate: How does this bioactive sphingolipid fit with acute neurological injury?

  2008influential citation
• The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis.

  2008cites this paper
• Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.

  2007cites this paper
• S1P1-Selective Agonist SEW2871 Exacerbates Reperfusion Arrhythmias

  2007cites this paper
• HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects Published, JLR Papers in Press, August 13, 2007.

  2007cites this paper
• Vascular effects of sphingolipids

  2007cites this paper
• Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia.

  2007cites this paper
• Modulation of Human Arterial Tone During Pregnancy: The Effect of the Bioactive Metabolite Sphingosine-1-Phosphate1

  2007cites this paper
• Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice.

  2007cites this paper
• Sphingosine-1-Phosphate Acts via Rho-Associated Kinase and Nitric Oxide to Regulate Human Placental Vascular Tone1

  2006cites this paper
• Vascular dysfunction in S 1 P 2 sphingosine 1-phosphate receptor knockout mice

  2006influential citation
• Influence of E-LDL and Ox-LDL on the metabolism of ApoE, cholesterol, sphingolipids and glycosphingolipids as well as on the raft-composition in human macrophages

  2006cites this paper
• Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.

  2006cites this paper
• Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine

  2006influential citation
• Sphingosine 1-phosphate-related metabolism in the blood vessel.

  2005cites this paper
• S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.

  2005cites this paper
• Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings.

  2005cites this paper
• The role of sphingosine-1-phosphate in smooth muscle contraction.

  2005cites this paper
• Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500268-JLR200

  2005cites this paper
• Platelet‐derived sphingosine 1‐phosphate induces contraction of coronary artery smooth muscle cells via S1P2

  2004cites this paper
• Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

  2004influential citation
• Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*

  2004cites this paper
• Sphingosine 1‐phosphate‐induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats

  2004cites this paper
• Mechanisms of cardioprotection by lysophospholipids

  2004cites this paper
• Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

  2004cites this paper
• High-Density Lipoprotein Stimulates Myocardial Perfusion In Vivo

  2004cites this paper
• Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

  2004influential citation
• Expression and functional characterization of SCaMPER: a sphingolipid-modulated calcium channel of cardiomyocytes.

  2003cites this paper
• Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm.

  2003cites this paper
• Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine

  2003cites this paper
• Fluid Shear Stress Differentially Regulates gpr3, gpr6, and gpr12 Expression in Human Umbilical Vein Endothelial Cells

  2003cites this paper
• Egress: a receptor‐regulated step in lymphocyte trafficking

  2003cites this paper
• Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist

  2003cites this paper
• Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

  2003cites this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.

  2002cites this paper
• Sphingosine modulation of cAMP levels and beating rate in rat heart

  2002cites this paper
• Molecular mechanisms of cardiostimulatory effects of sildenafil.

  2002cites this paper
• The Role of TNF α and Sphingolipid Signaling in Cardiac Hypoxia : Evidence that Cardiomyocytes Release TNF α and Sphingosine

  2002cites this paper
• Lysophospholipids and the cardiovascular system.

  2002cites this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts

  2002cites this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cites this paper
• Nifedipine inhibits sphingosine-1-phosphate-induced renovascular contraction in vitro and in vivo

  2001cites this paper
• Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

  2001cites this paper
• Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo.

  2001cites this paper
• Sphingosine 1-phosphate: synthesis and release.

  2001cites this paper
• EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.

  2001cites this paper
• Sphingosine‐1‐phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin‐sensitive manner

  2000cites this paper
• Hdl Serves as a S1p Signaling Platform Mediating a Multitude of Cardiovascular Effects the Source of S1p in Blood

  year unknowncites this paper